Literature DB >> 14637113

SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease.

D L Pountney1, Y Huang, R J Burns, E Haan, P D Thompson, P C Blumbergs, W P Gai.   

Abstract

Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder characterized by progressive ataxia and neuronal nuclear inclusions (NIs), similar to the inclusions found in expanded CAG repeat diseases. NIID may be familial or sporadic. The cause of familial NIID is poorly understood, as no CAG expansion has been detected. We examined three cases, from two unrelated families, who had autosomal dominant NIID but normal CAG repeats in genes involved in polyglutamine neurodegenerative diseases. We found that NIs in all three cases were intensely immunopositive for SUMO-1, a protein which covalently conjugates to other proteins and targets them to the nuclear regions (nuclear bodies) responsible for nuclear proteasomal degradation. Electron microscopy demonstrated that SUMO-1 was located on the 10-nm fibrils of NIs. In cultured PC12 cells, we found that inhibition of proteasome function by specific inhibitors resulted in the appearance of SUMO-1-immunopositive nuclear inclusions. Our study suggests that recruitment of SUMO-1 modified proteins into insoluble nuclear inclusions and proteasomal dysfunction may be involved in the pathogenesis of NIs in familial NIID cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637113     DOI: 10.1016/j.expneurol.2003.07.004

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  36 in total

Review 1.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 2.  Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.

Authors:  Hyoungseok Ju; Hiroshi Kokubu; Janghoo Lim
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

3.  Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease.

Authors:  Masataka Nakamura; Melissa E Murray; Wen-Lang Lin; Hirofumi Kusaka; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

4.  A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Krüppel-like factor 4.

Authors:  James X Du; Beth B McConnell; Vincent W Yang
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

5.  SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.

Authors:  Hong-Bin Luo; Yi-Yuan Xia; Xi-Ji Shu; Zan-Chao Liu; Ye Feng; Xing-Hua Liu; Guang Yu; Gang Yin; Yan-Si Xiong; Kuan Zeng; Jun Jiang; Keqiang Ye; Xiao-Chuan Wang; Jian-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-05       Impact factor: 11.205

6.  Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

Authors:  Kathryn McFadden; Ronald L Hamilton; Sam J Insalaco; Lawrence Lavine; Majeed Al-Mateen; Guoji Wang; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

7.  Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

Authors:  Jennifer Vermilion; Mahlon Johnson; Jayasri Srinivasan; Jonathan W Mink
Journal:  J Child Neurol       Date:  2019-07-15       Impact factor: 1.987

8.  SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.

Authors:  Mathew B Wong; Jacob Goodwin; Anwar Norazit; Adrian C B Meedeniya; Christiane Richter-Landsberg; Wei Ping Gai; Dean L Pountney
Journal:  Neurotox Res       Date:  2012-11-15       Impact factor: 3.911

Review 9.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

Review 10.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.